SCHEMBL18263134

SCHEMBL18263134

N#Cc1ccccc1-c1cnc(N)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.50
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48
ALOX5AP P20292 2/20 0.46
FEN1 P39748 2/20 0.46
ATR Q13535 2/20 0.44
PRKDC P78527 1/20 0.43
ATM Q13315 1/20 0.43
USP7 Q93009 4/20 0.43
TRPA1 O75762 1/20 0.43
CHEK1 O14757 1/20 0.42
PGR P06401 2/20 0.40
AR P10275 2/20 0.40
IKBKB O14920 1/20 0.40
GRM5 P41594 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
PTGES O14684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18263119 0.82 IL4 (0.43) GABRG2GABRB3GABRA5GABRA3ALOX5AP
SCHEMBL6169284 0.78 FEN1 (0.57) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL18263117 0.76 LCK (0.47) ALOX5APFEN1ATRPRKDCUSP7
SCHEMBL18263139 0.76 FEN1 (0.47) ALOX5APFEN1USP7CYP11B1CYP11B2
SCHEMBL5845273 0.76 ESR2 (0.59) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL488494 0.73 USP7 (0.62) USP7ALDH1A1
SCHEMBL18263158 0.73 EGLN1 (0.54) GABRG2GABRB3GABRA5GABRA3ATR
SCHEMBL14231513 0.71 ESR2 (0.56) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL7709223 0.70 ESR2 (0.50) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL17436061 0.70 ESR2 (0.50) ESR2GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3145935-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS DAG-LIPASE INHIBITORS Universiteit Leiden (NL) 2017-03-29 EP disclosed
WO-2016188972-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS DAG-LIPASE INHIBITORS UNIVERSITEIT LEIDEN (NL) 2016-12-01 WO disclosed
WO-2016188972-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS DAG-LIPASE INHIBITORS UNIVERSITEIT LEIDEN (NL) 2016-12-01 WO disclosed